The Latest Breaking News from Novartis

It's about delivering on corporate missions in a sustainable way, they said at Davos.

Pharmaceutical company Novartis (NVS) maintained its growth momentum in the third quarter of fiscal 2022, and the company’s growth prospects look promising, supported by its clear focus on five core therapeutic areas, having multiple significant in-market and pipeline assets. Given NVS’ reliable dividend payments and high profitability, this large-cap stock…

Unlike antiviral treatments, researchers say the experimental medication would not attack the virus that causes COVID-19, but target the immune system instead.

Biogen and Seagen tapped new CEOs on Thursday but the biotech stocks diverged following the long-anticipated announcements.

Novartis Ings 'opens' bringing pleasure at peaceful use to surviving relatives of German bomb blast

Novartis stock was mostly unmoved Tuesday after the company's earnings beat expectations, but third-quarter sales came up short.

Geneva (AFP) - Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.

Reuters Twitter Says Elon Musk Under Federal Probe Over $44B Twitter Deal, In Court Filing

Employees were informed of the phased cuts earlier today